Drawing for LUMEXA

USPTO serial 99657332

LUMEXA

Status 661
Filing date
Feb 17, 2026
Status date
Aug 6, 2026
Registration date
Examiner
RIOS, SASHA BOSHART

Need help with LUMEXA?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Owner

  • Magic Health Inc.

    New York City, NY, US

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of dermatological conditions, namely, acne, rosacea, and hyperpigmentation; none of the foregoing for the treatment of precancerous or cancerous skin lesions.ACTIVEFeb 1, 2026

Prosecution history

DateCodeEvent
Aug 6, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 6, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 31, 2026GNRTNON-FINAL ACTION E-MAILED
Jul 31, 2026CNRTNON-FINAL ACTION WRITTEN
Jun 19, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2026GNRTNON-FINAL ACTION E-MAILED
Jun 12, 2026CNRTNON-FINAL ACTION WRITTEN
Jun 9, 2026IUAAUSE AMENDMENT ACCEPTED
Jun 9, 2026DOCKASSIGNED TO EXAMINER
Feb 23, 2026AUPCAMENDMENT TO USE PROCESSING COMPLETE
Feb 23, 2026IUAFUSE AMENDMENT FILED
Feb 23, 2026EAAUTEAS AMENDMENT OF USE RECEIVED
Feb 17, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 17, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Feb 17, 2026NWAPNEW APPLICATION ENTERED

Related guidance